Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on Spexis Ltd. We currently have 3 research reports from 1 professional analysts.
| Date | Source | Announcement |
|---|---|---|
| 07Jul22 06:30 | EQS-News | Spexis' CXCR4 Inhibitor Balixafortide zeigt synergistische Wirksamkeit in Kombination mit Docetaxel in einem präklinischen Modell für metastasierenden Prostatakrebs |
| 07Jul22 06:30 | EQS-News | Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model |
| 19May22 06:30 | EQS-News | Spexis to present at H.C. Wainwright Global Investment Conference |
| 12May22 07:37 | RNS | Spexis AG - Spexis to present at BioEquity Europe 2022 |
| 12May22 06:30 | EQS-News | Spexis to present at BioEquity Europe 2022 |
| 27Apr22 08:20 | RNS | Spexis AG - Annual General Meeting |
| 27Apr22 06:15 | DGAP-AHD | Spexis Annual General Meeting 2022 |